LncRNAs Disease Experimental methods Regulated Pubmed ID Year
FTXnon small cell lung cancerqRT-PCR, Western blotL321764632019
FTXgastric cancerqRT-PCR, Western blot, RIPH320212482019
FTXcolorectal cancerqPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIPH299258532018
FTXhepatocellular carcinomaqPCR, Western blot, in vitro knockdown, RNAiH298451882018
FTXcolorectal cancerqPCR, Luciferase reporter assay etc.H322802422020
FTXgastric cancerqPCR, Western blot etcH322714212020
FTXlung adenocarcinomaqPCR, RIP etc.H322263112020
FTXosteosarcomaqRT-PCR, Western blotting, Dual-luciferase reporter analysis, RIPH319201412020
FTXosteosarcomaqPCRH319498472018
FTXuveal melanomaqPCR, RNAi, RNA-FISH, Cell migration and invasion assay etc.L283306942017
FTXgliomaqPCR, Cell transfection, Western blot, MTT assay etc.H281127562017
FTXhepatocellular carcinomaRIP etc.L270653312016
FTXrenal cell carcinomaqPCR, Cell proliferation assay, Cell cycle assay etc.H279839372017
FTXcolorectal cancerqPCR, RNAi etc.H266290532015
FTXhepatocellular carcinomaqPCR, RNAi, Western blot, Cell proliferation assay, MTT assay etc.H269922182016
FTXhepatocellular carcinomaqPCR, western blot etc.H298451882018
FTXcolorectal cancerqPCR, RIP, etc.H299258532018
FTXacute myeloid leukemiaMicroarray, qPCR, Western blot, Flow cytometry assay, RIP, etc.H298808182018